State Street Corp Beam Therapeutics Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, State Street Corp holds 3,929,557 shares of BEAM stock, worth $114 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,929,557
Previous 3,492,155 12.53%
Holding current value
$114 Million
Previous $81.8 Million 17.66%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$22.57 - $33.14 $9.87 Million - $14.5 Million
437,402 Added 12.53%
3,929,557 $96.3 Million
Q2 2024

Aug 14, 2024
SELL
$21.22 - $32.66 $5.07 Million - $7.81 Million
-239,037 Reduced 6.41%
3,492,155 $81.8 Million
Q1 2024

May 15, 2024
SELL
$23.46 - $45.07 $20.8 Million - $39.9 Million
-885,166 Reduced 19.17%
3,731,192 $123 Million
Q4 2023

Feb 14, 2024
BUY
$17.69 - $30.76 $8.39 Million - $14.6 Million
474,229 Added 11.45%
4,616,358 $126 Million
Q3 2023

Nov 14, 2023
BUY
$23.01 - $32.46 $12.8 Million - $18 Million
555,125 Added 15.48%
4,142,129 $99.6 Million
Q2 2023

Aug 14, 2023
BUY
$29.32 - $35.99 $10.3 Million - $12.6 Million
350,916 Added 10.84%
3,587,004 $115 Million
Q1 2023

May 15, 2023
BUY
$30.15 - $48.79 $4.29 Million - $6.94 Million
142,177 Added 4.6%
3,236,088 $99.1 Million
Q4 2022

Feb 14, 2023
BUY
$36.73 - $51.6 $19.5 Million - $27.4 Million
531,502 Added 20.74%
3,093,911 $121 Million
Q3 2022

Nov 15, 2022
SELL
$39.79 - $70.31 $30.8 Million - $54.4 Million
-773,918 Reduced 23.2%
2,562,409 $122 Million
Q2 2022

Aug 15, 2022
BUY
$29.86 - $62.36 $40.5 Million - $84.5 Million
1,354,781 Added 68.37%
3,336,327 $129 Million
Q1 2022

May 16, 2022
BUY
$53.73 - $82.16 $16 Million - $24.5 Million
298,383 Added 17.73%
1,981,546 $114 Million
Q4 2021

Feb 14, 2022
BUY
$68.02 - $99.06 $19.1 Million - $27.9 Million
281,443 Added 20.08%
1,683,163 $134 Million
Q3 2021

Nov 15, 2021
BUY
$84.37 - $133.6 $6.86 Million - $10.9 Million
81,345 Added 6.16%
1,401,720 $122 Million
Q2 2021

Aug 16, 2021
BUY
$64.12 - $128.71 $6.55 Million - $13.1 Million
102,104 Added 8.38%
1,320,375 $170 Million
Q1 2021

May 17, 2021
SELL
$71.28 - $120.75 $15.1 Million - $25.6 Million
-212,139 Reduced 14.83%
1,218,271 $97.5 Million
Q4 2020

Feb 16, 2021
BUY
$22.24 - $95.63 $20 Million - $86 Million
898,932 Added 169.14%
1,430,410 $117 Million
Q3 2020

Nov 10, 2020
BUY
$19.0 - $30.57 $5.86 Million - $9.42 Million
308,179 Added 138.01%
531,478 $13.1 Million
Q2 2020

Aug 14, 2020
BUY
$15.26 - $28.66 $517,588 - $972,089
33,918 Added 17.91%
223,299 $6.25 Million
Q1 2020

May 11, 2020
BUY
$13.31 - $29.2 $2.52 Million - $5.53 Million
189,381 New
189,381 $3.41 Million

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $2.04B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email